MPE at ASH 2024: key research and expert insights on myelomaAL amyloidosis, CAR-T, Conferences, MPE, Myeloma16 December 2024
Myeloma and AL amyloidosis ASH 2024 previewAccess, AL amyloidosis, CAR-T, MPE, Myeloma29 November 2024
European Commission approves CAR T-cell therapy ciltacabtagene autoleucel in earlier lines of therapy for relapsed and refractory myelomaAccess, CAR-T, Myeloma23 April 2024
